CompoAtlas

CREATINE +

Food supplement declared in France, decision dated 31 October 2026

CREATINE + (CURE BY LA S) is a food supplement declared in France. Status: declared in France, may be marketed. None of the rules we check flags an issue with its declared composition.

Brand
CURE BY LA S
Food business operator placing the product on the market
MELISSA ZENNOUCHE (CURE BY LA S)
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Capsule
Daily dose
4 gélules
Directions for use
Prendre 4 gélules par jour au cours d'un repas (en 1 ou 2 prises). En cas de sport, prendre les 4 gélules avec un verre d'eau juste avant la séance.
Intended populations
General population
Not recommended (according to the manufacturer)
Adolescents (under 18)
Objectives stated by the manufacturer (these are not authorised claims)
Sport

Declaration 381034, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Other active ingredients

NamePer day
Créatine monohydratenot declared

Additives

E464

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Label warnings

Tenir hors de la portée des jeunes enfants. Ne pas dépasser la portion journalière recommandée. A conserver dans un endroit frais et sec. Les compléments alimentaires ne peuvent être utilisés comme substituts d'un régime alimentaire varié et équilibré et d'un mode de vie sain.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Créatine monohydrate
    Read the warning, when it applies and the studies cited

    Creatine Monohydrate

    Route of administration: Oral

    Cautions and warnings

    When using this product you may gain weight (Volek and Rawson 2004; Bemben et al. 2001; Mihic et al. 2000).

    Sources cited by Health Canada (3)
    • Bemben MG, Bemben DA, Loftiss DD, Knehans AW. 2001. Creatine supplementation during resistance training in college football athletes. Medicine & Science in Sports & Exercise 33(10):1667-1673.
    • Mihic S, MacDonald JR, McKenzie S, Tarnopolsky MA. 2000. Acute creatine loading increases fat-free mass, but does not affect blood pressure, plasma creatinine, or CK activity in men and women. Medicine & Science in Sports and Exercise 32(2):291-296.
    • Volek JS, Rawson ES. 2004. Scientific basis and practical aspects of creatine supplementation for athletes. Nutrition 20(7-8):609-614.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a kidney disorder (Pline and Smith 2005; Pritchard and Kalra 1998).

    Sources cited by Health Canada (2)
    • Pline KA, Smith CL. 2005. The effect of creatine intake on renal function. The Annals of Pharmacotherapy 39(6):1093-1096.
    • Pritchard NR, Kalra PA. 1998. Renal dysfunction accompanying oral creatine supplements. The Lancet 351(9111):1252-1253.

    Health Canada monograph dated 28 June 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Other declarations with the same name

This name is used by more than 10 declarations from different companies, so it does not identify one product. See every declaration with this name.

Brand : CURE BY LA S

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line